Impact of a shorter replacement interval of plastic stents on premature stent exchange rate in benign and malignant biliary strictures.
biliary stricture
double-pigtail stents
endoscopic retrograde cholangiography
stent patency
Journal
Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
23
01
2022
received:
01
11
2021
accepted:
21
02
2022
pubmed:
10
3
2022
medline:
18
6
2022
entrez:
9
3
2022
Statut:
ppublish
Résumé
The main disadvantage of plastic stents is the high rate of stent occlusion. The usual replacement interval of biliary plastic stents is 3 months. This study aimed to investigate if a shorter interval of 6-8 weeks impacts the median premature exchange rate (mPER) in benign and malignant biliary strictures. All cases with endoscopic retrograde cholangiopancreatography (ERCP) and plastic stent placement were retrospectively analyzed since establishing an elective replacement interval of every 6-8 weeks at our institution and mPER was determined. A total of 3979 ERCPs (1199 patients) were analyzed, including 1262 (31.7%) malignant and 2717 (68.3%) benign cases, respectively. The median stent patency (mSP) was 41 days (range 14-120) for scheduled stent exchanges, whereas it was 17 days (1-75) for prematurely exchanged stents. The mPER was significantly higher for malignant (28.1%, 35-50%) compared with benign strictures (15.2%, 10-28%), P < 0.0001, respectively. mSP was significantly shorter in cases with only one stent (34 days [1-87] vs 41 days [1-120]) and in cases with only a 7-Fr stent (28 days [2-79]) compared with a larger stent (34 days [1-87], P = 0.001). Correspondingly, mPER was significantly higher in cases with only one stent (23% vs 16.2%, P < 0.0001) and only a 7-Fr stent (31.3% vs 22.4%, P = 0.03). A shorter replacement interval does not seem to lead to a clinically meaningful reduction of mPER in benign and malignant strictures. Large stents and multiple stenting should be favored as possible.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
The main disadvantage of plastic stents is the high rate of stent occlusion. The usual replacement interval of biliary plastic stents is 3 months. This study aimed to investigate if a shorter interval of 6-8 weeks impacts the median premature exchange rate (mPER) in benign and malignant biliary strictures.
METHODS
METHODS
All cases with endoscopic retrograde cholangiopancreatography (ERCP) and plastic stent placement were retrospectively analyzed since establishing an elective replacement interval of every 6-8 weeks at our institution and mPER was determined.
RESULTS
RESULTS
A total of 3979 ERCPs (1199 patients) were analyzed, including 1262 (31.7%) malignant and 2717 (68.3%) benign cases, respectively. The median stent patency (mSP) was 41 days (range 14-120) for scheduled stent exchanges, whereas it was 17 days (1-75) for prematurely exchanged stents. The mPER was significantly higher for malignant (28.1%, 35-50%) compared with benign strictures (15.2%, 10-28%), P < 0.0001, respectively. mSP was significantly shorter in cases with only one stent (34 days [1-87] vs 41 days [1-120]) and in cases with only a 7-Fr stent (28 days [2-79]) compared with a larger stent (34 days [1-87], P = 0.001). Correspondingly, mPER was significantly higher in cases with only one stent (23% vs 16.2%, P < 0.0001) and only a 7-Fr stent (31.3% vs 22.4%, P = 0.03).
CONCLUSION
CONCLUSIONS
A shorter replacement interval does not seem to lead to a clinically meaningful reduction of mPER in benign and malignant strictures. Large stents and multiple stenting should be favored as possible.
Substances chimiques
Plastics
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1076-1082Informations de copyright
© 2022 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Moy BT, Birk JW. An update to hepatobiliary stents. J. Clin. Transl. Hepatol. 2015: 67-77.
Huibregtse K, Cheng J, Coene PPLO, Fockens P, Tytgat GNJ. Endoscopic placement of expandable metal stents for biliary strictures-a preliminary report on experience with 33 patients. Endoscopy 1989; 21: 280-282. https://doi.org/10.1055/s-2007-1012969
Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-1492. https://doi.org/10.1016/0140-6736(92)92752-2
Dumonceau JM, Tringali A, Papanikolaou IS et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline-updated October 2017. Endoscopy 2018: 910-930.
Leong QW, Shen ML, Au KW et al. A prospective, randomized study of the patency period of the plastic antireflux biliary stent: an interim analysis. Gastrointest. Endosc. 2016; 83: 387-393. https://doi.org/10.1016/j.gie.2015.04.027
van Berkel A, Bruno MJ, Bergman JJGHM, van Deventer S, Tytgat GN, Huibregtse K. A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction. Endoscopy 2003: 478-482.
Costamagna G, Mutignani M, Rotondano G et al. Hydrophilic hydromer-coated polyurethane stents versus uncoated stents in malignant biliary obstruction: a randomized trial. Gastrointest. Endosc. 2000; 51: 8-11. https://doi.org/10.1016/S0016-5107(00)70378-6
Leung JW, Libby ED, Morck DW et al. Is prophylactic ciprofloxacin effective in delaying biliary stent blockage? Gastrointest. Endosc. 2000; 52: 175-182. https://doi.org/10.1067/mge.2000.107716
Halm U, Schiefke I, Fleig WE, Mössner J, Keim V. Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. Endoscopy 2001; 33: 491-494. https://doi.org/10.1055/s-2001-14963
Kwon CI, Lehman GA. Mechanisms of biliary plastic stent occlusion and efforts at prevention. Clin. Endosc. 2016; 49: 139-146. https://doi.org/10.5946/ce.2016.024
Costamagna G, Pandolfi M, Mutignani M, Spada C, Perri V. Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents. Gastrointest. Endosc. 2001; 54: 162-168. https://doi.org/10.1067/mge.2001.116876
Martins FP, De Paulo GA, Contini MLC, Ferrari AP. Metal versus plastic stents for anastomotic biliary strictures after liver transplantation: a randomized controlled trial. Gastrointest. Endosc. 2018; 87: 131.e1-131.e13. https://doi.org/10.1016/j.gie.2017.04.013
Kaffes A, Griffin S, Chua T et al. A randomized trial of a fully covered self-expandable metallic stent versus plastic stents in anastomotic biliary strictures after liver transplantation. Therap. Adv. Gastroenterol. 2014: 64-71. https://doi.org/10.1177/1756283X13503614
Lawrence C, Romagnuolo J, Payne KM, Hawes RH, Cotton PB. Low symptomatic premature stent occlusion of multiple plastic stents for benign biliary strictures: comparing standard and prolonged stent change intervals. Gastrointest. Endosc. 2010; 72: 558-563. https://doi.org/10.1016/j.gie.2010.05.029
Ge PS, Hamerski CM, Watson RR et al. Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy. Gastrointest. Endosc. 2015; 81: 360-366. https://doi.org/10.1016/j.gie.2014.08.020
Boulay BR, Gardner TB, Gordon SR. Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction. J. Clin. Gastroenterol. 2010; 44: 452-455. https://doi.org/10.1097/MCG.0b013e3181d2ef06
Varadhachary GR, Wolff RA, Crane CH et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J. Clin. Oncol. 2008; 26: 3487-3495. https://doi.org/10.1200/JCO.2007.15.8642
Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat. Rev. 2007; 33: 213-221. https://doi.org/10.1016/j.ctrv.2006.10.006
Perdue DG, Freeman ML, DiSario J et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J. Clin. Gastroenterol. 2008; 42: 1040-1046. https://doi.org/10.1097/MCG.0b013e31815853e0
Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest. Endosc. 2012: 93-99.
Mukai T, Yasuda I, Nakashima M et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J. Hepatobiliary Pancreat. Sci. 2013: 214-222. https://doi.org/10.1007/s00534-012-0508-8